Cardiovascular effects and safety of (non-aspirin) NSAIDs
AM Schjerning, P McGettigan, G Gislason - Nature Reviews Cardiology, 2020 - nature.com
Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely used analgesics. For
the past 2 decades, considerable attention has been focused on their cardiovascular safety …
the past 2 decades, considerable attention has been focused on their cardiovascular safety …
Select Drug-Drug Interactions With Direct Oral Anticoagulants: JACC Review Topic of the Week
Millions of individuals in the United States require long-term treatment with an oral
anticoagulant. For decades, vitamin K antagonists were the only oral option available; …
anticoagulant. For decades, vitamin K antagonists were the only oral option available; …
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
CT Ruff, RP Giugliano, E Braunwald, EB Hoffman… - The Lancet, 2014 - thelancet.com
Background Four new oral anticoagulants compare favourably with warfarin for stroke
prevention in patients with atrial fibrillation; however, the balance between efficacy and …
prevention in patients with atrial fibrillation; however, the balance between efficacy and …
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …
Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
C Chai-Adisaksopha, M Crowther… - Blood, The Journal …, 2014 - ashpublications.org
Vitamin K antagonists (VKAs) have been the standard of care for treatment of
thromboembolic diseases. Target-specific oral anticoagulants (TSOACs) have been …
thromboembolic diseases. Target-specific oral anticoagulants (TSOACs) have been …
2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation
L Macle, J Cairns, K Leblanc, T Tsang, A Skanes… - Canadian Journal of …, 2016 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines
Committee provides periodic reviews of new data to produce focused updates that address …
Committee provides periodic reviews of new data to produce focused updates that address …
Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
Background Atrial fibrillation is an important cause of morbidity and mortality worldwide, but
scant data are available for long-term outcomes in individuals outside North America or …
scant data are available for long-term outcomes in individuals outside North America or …
New oral anticoagulants in elderly adults: evidence from a meta‐analysis of randomized trials
P Sardar, S Chatterjee, S Chaudhari… - Journal of the …, 2014 - Wiley Online Library
Objectives To evaluate the efficacy and safety of new oral anticoagulants (NOAC s) in
elderly adults. Design Meta‐analyses of randomized clinical trials (RCT s). Setting PubMed …
elderly adults. Design Meta‐analyses of randomized clinical trials (RCT s). Setting PubMed …
New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new …
Importance Randomized studies have shown a decreased risk of intracranial hemorrhage
(ICH) with use of novel oral anticoagulants (NOACs). However, it is unclear whether the …
(ICH) with use of novel oral anticoagulants (NOACs). However, it is unclear whether the …
Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction
AMS Olsen, GH Gislason, P McGettigan, E Fosbøl… - Jama, 2015 - jamanetwork.com
Importance Antithrombotic treatment is indicated for use in patients after myocardial
infarction (MI); however, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) …
infarction (MI); however, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) …